The Bombay Stock Exchange (BSE) building, left, looms over a no-entry street sign in Mumbai. (Photographer: Prashanth Vishwanathan/Bloomberg)

Sensex, Nifty Fall For Second Straight Day Led By Decline In ICICI Bank

Latest First
  • Oldest First

BQ Live

Sensex Drops 369 Points, Nifty Settles Below 10,700

Indian equity benchmarks extended decline to second day led by losses in ICICI Bank, Reliance Industries and HDFC.

The S&P BSE Sensex fell 1.02 percent or 369 points to 35,657 and the NSE Nifty 50 Index dropped 1.10 percent or 119 points to 10,662.

Seventeen of 19 sector gauges compiled by BSE ended lower led by S&P BSE Finance Index's 2.1 percent decline. S&P BSE Basic Materials and S&P BSE Healthcare indices also fell over 2 percent in today's trade. On the flipside, S&P BSE Teck Index was top gainer, up 0.8 percent.

Mid- and small-cap shares underperformed their larger peers as the S&P BSE MidCap Index fell 1.84 percent and the S&P BSE SmallCap Index dropped 2 percent.

Tata Power Extends Decline After Profit Miss Estimates In Q3

Shares of the Mumba-based power producer fell as much as 5.88 percent to Rs 69.60 after its profit missed Bloomberg consensus estimates in December quarter.

Key earnings highlights:

  • Revenue at Rs 7,710 crore versus estimate of Rs 7,803 crore
  • Net profit at Rs 127 crore versus estimate of Rs 466 crore

Zee Entertainment Exends Gain, Surges 20%

Shares of the Mumbai-based media company extended gains and rose as much as 20 percent to Rs 382 after lenders having a pledge on the Zee Group promoters’ shares have granted time until April to repay dues after they sold 0.6 percent stake in the group’s flagship on Friday.

Orient Electric Extends Slide After Profit Declines In Q3

Shares of the Delhi-based electrical products maker fell as much as 6.57 percent to Rs 135 after its profit declined in December quarter.

Key earnings highlights:

  • Revenue at Rs 420 crore versus Rs 346 crore (YoY)
  • Net profit at Rs 11.76 crore versus Rs 12.17 crore (YoY)

Wockhardt Extends Decline After Loss Widens In Q3

Shares of the Mumbai-based pharma company extended decline and fell as much as 8.17 percent to Rs 440 after its loss widened in December quarter.

Key earnings highlights:

  • Revenue at Rs 1,045 crore versus Rs 1,005 crore (YoY)
  • Net loss at Rs 71.11 crore versus loss of Rs 40.76 crore (YoY)